FLGT

16.86

0.82% -0.14

Dopo l'orario di chiusura: 16.66 -0.20 -1.19%

Fulgent Genetics Inc (FLGT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$17.00

Aprire:

$16.59

Volume 24 ore:

419.54K

Relative Volume:

1.06

Capitalizzazione di mercato:

$520.40M

Reddito:

$290.71M

Utile/perdita netta:

$-163.43M

Rapporto P/E:

-3.0766

EPS:

-5.48

Flusso di cassa netto:

$11.70M

1 W Prestazione:

-1.11%

1M Prestazione:

+8.63%

6M Prestazione:

-19.29%

1 anno Prestazione:

-20.51%

Intervallo 1D:

$16.59

$17.36

Intervallo di 1 settimana:

$16.57

$17.64

Portata 52W:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Nome

Fulgent Genetics Inc

Settore

Healthcare (1171)

Industria

Diagnostics & Research (58)

Telefono

626-350-0537

Indirizzo

4399 SANTA ANITA AVE, EL MONTE

Dipendente

1,313

Cinguettio

@FulgentGenetics

Prossima data di guadagno

2024-11-08

Ultimi documenti SEC

FLGT's Discussions on Twitter

Confronta FLGT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FLGT Fulgent Genetics Inc	16.86	520.40M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	437.91	165.21B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	181.77	130.05B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	393.73	31.91B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	103.00	29.38B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	154.73	27.28B	15.41B	1.37B	2.11B	7.50

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-07	Iniziato	UBS	Neutral
2022-12-08	Downgrade	Piper Sandler	Overweight → Neutral
2022-11-18	Iniziato	Raymond James	Outperform
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-02-04	Ripresa	Piper Sandler	Overweight
2021-08-05	Ripresa	Credit Suisse	Underperform
2021-01-08	Downgrade	Credit Suisse	Neutral → Underperform
2020-11-24	Downgrade	BTIG Research	Buy → Neutral
2020-08-20	Iniziato	Oppenheimer	Outperform
2020-05-29	Iniziato	BTIG Research	Buy
2019-11-05	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-03-01	Downgrade	Piper Jaffray	Overweight → Neutral
2017-11-07	Downgrade	Raymond James	Outperform → Mkt Perform

Mostra tutto

Fulgent Genetics Inc Borsa (FLGT) Ultime notizie

Apr 02, 2025

Diametric Capital LP Acquires Shares of 38,818 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Apr 02, 2025

Mar 31, 2025

Quantbot Technologies LP Has $192,000 Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 31, 2025

Where are the Opportunities in (FLGT) - news.stocktradersdaily.com

Mar 31, 2025

Mar 30, 2025

Charles Schwab Investment Management Inc. Has $3.88 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Proficio Capital Partners LLC Purchases New Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 29, 2025

Mar 28, 2025

PNC Financial Services Group Inc. Sells 2,046 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 28, 2025

Mar 27, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Intech Investment Management LLC - MarketBeat

Mar 27, 2025

Mar 26, 2025

Magnetar Financial LLC Invests $314,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 26, 2025

Mar 25, 2025

A better buy-in window may exist right now for Fulgent Genetics Inc (FLGT) - SETE News

Mar 25, 2025

Mar 24, 2025

Bank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 24, 2025

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Purchases 112,011 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 23, 2025

Mar 22, 2025

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy - Seeking Alpha

Mar 20, 2025

Mar 15, 2025